One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-143265
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: Memorial Sloan Kettering Cancer Center, University of Chicago Medical Center, Oregon Health & Science University, The Ohio State University, Jacksonville College, Mayo Clinic, Winneshiek Medical Center, University of California, Los Angeles, Southwestern Medical Center, The University of Texas Southwestern Medical Center, UPMC Hillman Cancer Center, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Leukemia and Lymphoma Society, Emory University, James Cancer Hospital, Huntsman Cancer Institute, University of Maryland, Baltimore, University of North Carolina at Chapel Hill, University of Kansas
Enasidenib (ENA) Monotherapy with Addition of Azacitidine in Non-Responders Is Effective in Older Patients with Newly Diagnosed IDH2 Mutated Acute Myeloid Leukemia (AML): A Completed Phase 2/1b Sub-Study of the Beat AML Master Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
